BIOTECH TARGET N V — SEC Form 4 filings

SEC reporting owner CIK 1259870. 2 Form 4 filings on record with FilingPulse; latest filed 2024-11-18.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-04-04 to 2024-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Molecular Templates, Inc. (MTEM)10% owner21 leg · 250,000 sh · $587,5001 leg · 1,279,820 sh · $845,8334

Form 4 filings — BIOTECH TARGET N V

FiledFormIssuerReported transactionsSource
2024-11-184Molecular Templates, Inc. (MTEM)
jointly with BB BIOTECH AG
Sale (S): 1,279,820 @ $0.66 · Purchase (P): 134,667 (derivative) @ $2.35 · Purchase (P): 769,334 (derivative) @ $0.12EDGAR
2024-04-044Molecular Templates, Inc. (MTEM)
jointly with BB BIOTECH AG
Purchase (P): 250,000 @ $2.35 · Purchase (P): 134,667 (derivative) @ $2.35 · Purchase (P): 769,334 (derivative) @ $0.12EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1259870 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →